Loading clinical trials...
Loading clinical trials...
A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors
Conditions
Interventions
INCB 99280 with Ipilimumab
Locations
8
United States
Valkyrie Clinical Trials
Los Angeles, California, United States
UC Irvine Medical Center
Orange, California, United States
Sharp Memorial Hospital
San Diego, California, United States
Henry Ford Health System
Detroit, Michigan, United States
Alliance For Multispecialty Research Llc
Knoxville, Tennessee, United States
Princess Margaret Cancer Center
Toronto, Ontario, Canada
Start Date
August 29, 2023
Primary Completion Date
September 19, 2024
Completion Date
November 11, 2024
Last Updated
February 18, 2025
NCT03340506
NCT05969860
NCT04693377
NCT07117227
NCT04895709
NCT05111574
Lead Sponsor
Incyte Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions